Abstract
Induced pluripotent stem (iPS) cell research has been growing a new height throughout the world due to its potentialities in medical applications. We can explore several therapeutic applications through the iPS cell research. In this review, we have first discussed the development of iPS cells, reprogramming factors, and effectiveness of iPS cells. Then we have emphasized the potential applications of iPS cells in pharmaceutical and medical sectors, such as, study of cellular mechanisms for spectrum of disease entities, disease-specific iPS cell lines for drugs discovery and development, toxicological studies of drugs development, personalized medicine, and regenerative medicine.
Keywords: Induced pluripotent stem (iPS) cell, disease-specific iPS cell lines, drug discovery and development, toxicological studies, personalized medicine, regenerative medicine, Yamanaka Factors, blastomeres, HMG-box, histone acetyltransferases, c-Myc, Nanog, pluripotency, retrovirus, lentivirus, doxycycline, keratinocytes, neurodegenerative disorders, amyotrophic lateral sclerosis, spinal muscular atrophy, Huntington's disease, Alzheimer's disease, Parkinson's disease, Anderson-Fabry disease, transplantation
Current Molecular Medicine
Title: Potentialities of Induced Pluripotent Stem (iPS) Cells for Treatment of Diseases
Volume: 10 Issue: 8
Author(s): C. Chakraborty, K. D. Shah, W. G. Caob, C. H. Hsu, Z. H. Wen and C. S. Lin
Affiliation:
Keywords: Induced pluripotent stem (iPS) cell, disease-specific iPS cell lines, drug discovery and development, toxicological studies, personalized medicine, regenerative medicine, Yamanaka Factors, blastomeres, HMG-box, histone acetyltransferases, c-Myc, Nanog, pluripotency, retrovirus, lentivirus, doxycycline, keratinocytes, neurodegenerative disorders, amyotrophic lateral sclerosis, spinal muscular atrophy, Huntington's disease, Alzheimer's disease, Parkinson's disease, Anderson-Fabry disease, transplantation
Abstract: Induced pluripotent stem (iPS) cell research has been growing a new height throughout the world due to its potentialities in medical applications. We can explore several therapeutic applications through the iPS cell research. In this review, we have first discussed the development of iPS cells, reprogramming factors, and effectiveness of iPS cells. Then we have emphasized the potential applications of iPS cells in pharmaceutical and medical sectors, such as, study of cellular mechanisms for spectrum of disease entities, disease-specific iPS cell lines for drugs discovery and development, toxicological studies of drugs development, personalized medicine, and regenerative medicine.
Export Options
About this article
Cite this article as:
Chakraborty C., D. Shah K., G. Caob W., H. Hsu C., H. Wen Z. and S. Lin C., Potentialities of Induced Pluripotent Stem (iPS) Cells for Treatment of Diseases, Current Molecular Medicine 2010; 10 (8) . https://dx.doi.org/10.2174/156652410793384178
DOI https://dx.doi.org/10.2174/156652410793384178 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease
Current Genomics Neural Stem Cells and Human Induced Pluripotent Stem Cells to Model Rare CNS Diseases
CNS & Neurological Disorders - Drug Targets Tackling Chronic Pain and Inflammation through the Purinergic System
Current Medicinal Chemistry A Novel Physico-Chemical Property Based Model for Studying the Effects of Mutation on the Aggregation of Peptides
Protein & Peptide Letters subject Index To Volume 1
Current Drug Targets - CNS & Neurological Disorders Common Genetic Variants of the Mitochondrial Trafficking System and Mitochondrial Uncoupling Proteins Affect the Development of Two Slowly Developing Demyelinating Disorders, Leukoaraiosis and Multiple Sclerosis
Current Medicinal Chemistry Translocator Protein (TSPO) Role in Aging and Alzheimer’s Disease
Current Aging Science Transient Cerebral Ischemia Leads to TGF-β2 Expression in Golgi Apparatus Organelles
Current Neurovascular Research AMPA Receptor Antagonists: Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Apolipoprotein E4 Serum Concentration for Increased Sensitivity and Specificity of Diagnosis of Drug Treated Alzheimer’s Disease Patients vs. Drug Treated Parkinson’s Disease Patients vs. Age-matched Normal Controls
Current Alzheimer Research Mood Stabilizers, Oxidative Stress and Antioxidative Defense in Euthymia of Bipolar Disorder
CNS & Neurological Disorders - Drug Targets Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design
Current Neuropharmacology Intrinsically Disordered Domains, Amyloids and Protein Liquid Phases: Evolving Concepts and Open Questions
Protein & Peptide Letters Novel Therapeutic Strategies in Major Depression: Focus on RNAi and Ketamine
Current Pharmaceutical Design Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping
Current Computer-Aided Drug Design The Journey From Metabolic Profiling to Biomarkers: The Potential of NMR Spectroscopy Based Metabolomics in Neurodegenerative Disease Research
Current Metabolomics The Variable Presentations of Glycogen Storage Disease Type IV: A Review of Clinical, Enzymatic and Molecular Studies
Current Molecular Medicine Synthetic Methods for the Preparation of Triazepandiones and Review of their Applications
Current Organic Chemistry Neurotrophic Effects of the Peptide NAP: A Novel Neuroprotective Drug Candidate
Current Alzheimer Research